Brandon Lam

Stanford Medicine — United States

Immunology and Microbiology · Life Sciences

18h-index1.1kcitations73works7.42yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Immunotherapy and Immune Responses(11), Systemic Lupus Erythematosus Research(9), Cytokine Signaling Pathways and Interactions(9), T-cell and B-cell Immunology(8), SARS-CoV-2 and COVID-19 Research(8)

Publications73 total

AlphaFold3 for Structure-guided Ligand Discovery
2025· 3 citedOpen Access
Drivers of differential antibody breadth in SARS-CoV-2 mRNA vaccination and infection 4823
The Journal of Immunology·2025Open Access
Immunoglobulin heavy chain locus duplication in bats 4518
The Journal of Immunology·2025Open Access
Convergent Features and Cross-reactivity Patterns in Human Memory B-cell Repertoires Against Seasonal and Avian Influenza Strains 9182
The Journal of Immunology·2025Open Access
Benchmarking overlapping community detection methods for applications in human connectomics
Network Neuroscience·2025Open Access
Benchmarking overlapping community detection methods for applications in human connectomics
2025Open Access
Disease diagnostics using machine learning of B cell and T cell receptor sequences
Science·2025· 50 citedOpen Access
Gestational SARS-CoV-2 Infection in a Ugandan Birth Cohort: High Incidence, Mild Maternal Disease, and Evidence of Association with Transient Infant Stunting
American Journal of Tropical Medicine and Hygiene·2024· 1 citedOpen Access
Impaired innate and adaptive immune responses to BNT162b2 SARS-CoV-2 vaccination in systemic lupus erythematosus
JCI Insight·2024· 12 citedOpen Access
Profiling of VEGF Receptors and Immune Checkpoints in Recurrent Respiratory Papillomatosis
The Laryngoscope·2024· 8 citedOpen Access
In situ vaccination via tissue-targeted cDC1 expansion enhances the immunogenicity of chemoradiation and immunotherapy
Journal of Clinical Investigation·2023· 18 citedOpen Access
High rates of SARS-CoV-2 infection in pregnant Ugandan women and association with stunting in infancy
2023Open Access
Development and anticancer properties of Up284, a spirocyclic candidate ADRM1/RPN13 inhibitor
PLoS ONE·2023· 4 citedOpen Access
Detection of SARS-CoV-2 Antibodies in Immunoglobulin Products
The Journal of Allergy and Clinical Immunology In Practice·2023· 16 citedOpen Access
Organoid modeling of lung-resident immune responses to SARS-CoV-2 infection
2023· 13 citedOpen Access
Data from Development of a Novel Mouse Model of Spontaneous High-Risk HPVE6/E7–Expressing Carcinoma in the Cervicovaginal Tract
2023Open Access
Data from Development of a Novel Mouse Model of Spontaneous High-Risk HPVE6/E7–Expressing Carcinoma in the Cervicovaginal Tract
2023Open Access
Supplementary Data from Development of a Novel Mouse Model of Spontaneous High-Risk HPVE6/E7–Expressing Carcinoma in the Cervicovaginal Tract
2023Open Access
Supplementary Data from Development of a Novel Mouse Model of Spontaneous High-Risk HPVE6/E7–Expressing Carcinoma in the Cervicovaginal Tract
2023Open Access
Supplementary Tables from Development of a Novel Mouse Model of Spontaneous High-Risk HPVE6/E7–Expressing Carcinoma in the Cervicovaginal Tract
2023Open Access
page 1 of 4Next →

Frequent Co-authors

Chien‐Fu Hung(15), Joseph Larkin(9), T.‐C. Wu(9), Yu Jui Kung(8), Scott D. Boyd(7), Katharina Röltgen(6), John Lin(6), Ssu-Hsueh Tseng(6), Emily Farmer(5), Ssu-Hsueh Tseng(5), Ya Chea Tsai(5), Richard B.S. Roden(5), Michael E. von Fricken(5), Teresa D. Collins(5), Benjamin A. Pinsky(4), Louise Ferrall(4), Deyin Xing(4), Erin Craig(3), Ramona A. Hoh(3), Charlotte Cunningham‐Rundles(3)